$4.23
0.05[1.20%]
At close: Apr 26
$4.23
0[0.00%]
After Hours: 4:20PM EDT
MannKind
(NASDAQ:MNKD)Latest News for MannKind Stock (NASDAQ:MNKD)
MannKind Stock (NASDAQ: MNKD)
Categories: All
Tuesday, March 26, 2024
Friday, March 15, 2024
Monday, March 11, 2024
- Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 11, 2024, 1:41PM
- EQT, Genie Energy And Other Big Stocks Moving Lower On MondayAvi Kapoor - Mar 11, 2024, 10:37AM
- What's Going On With MannKind Stock?Erica Kollmann - Mar 11, 2024, 10:28AM
- MannKind Announced Initial Meal Challenge Data From INHALE-3 Phase 4 U.S. Trial Comparing Afrezza Head-to-head With Multiple Daily Injections And Insulin PumpsBenzinga Newsdesk - Mar 11, 2024, 6:13AM
Friday, March 08, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
Thursday, January 04, 2024
Tuesday, January 02, 2024
- Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Jan 2, 2024, 1:35PM
- MannKind shares are trading higher after the company announced it entered into a royalty purchase agreement with Sagard Healthcare for up to $200 million.Benzinga Newsdesk - Jan 2, 2024, 10:31AM
- MannKind Sold A 1% Royalty In Net Sales Of Tyvaso DPI (Treprostinil) Inhalation Powder In Exchange For Up To $200M, Including The Purchase Price Of $150M And An Additional Potential Milestone Payment Of Up To $50MBenzinga Newsdesk - Jan 2, 2024, 6:10AM
Wednesday, December 27, 2023
Wednesday, December 20, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Tuesday, October 10, 2023
- MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback'Priya Nigam - Oct 10, 2023, 12:57PM
- MannKind shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and a $10 price target.Benzinga Newsdesk - Oct 10, 2023, 11:46AM
- Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023Benzinga Insights - Oct 10, 2023, 11:00AM
- Wedbush Initiates Coverage On MannKind with Outperform Rating, Announces Price Target of $10Benzinga Newsdesk - Oct 10, 2023, 5:13AM
Monday, August 14, 2023
Tuesday, August 08, 2023
- Cantor Fitzgerald Maintains Overweight on MannKind, Raises Price Target to $7.5Benzinga Newsdesk - Aug 8, 2023, 1:31PM
- Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Aug 8, 2023, 1:13PM
- Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On TuesdayLisa Levin - Aug 8, 2023, 10:35AM
Monday, August 07, 2023
- UPDATE: MannKind Q2 Adj. EPS $0.00 Beats $(0.04) Estimate, Sales $48.61M Beat $42.03M EstimateHappy Mohamed - Aug 7, 2023, 5:20PM
- MannKind Q2 Adj. EPS $0.00 Beats $(0.04) Estimate, Sales $48.61M Beat $42.03M EstimateBenzinga Newsdesk - Aug 7, 2023, 4:01PM
- Earnings Scheduled For August 7, 2023Benzinga Insights - Aug 7, 2023, 4:12AM
Friday, August 04, 2023
Thursday, May 11, 2023
Wednesday, May 10, 2023
- Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - May 10, 2023, 12:59PM
- Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On WednesdayLisa Levin - May 10, 2023, 11:35AM
- MannKind shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.Benzinga Newsdesk - May 10, 2023, 11:06AM